Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: redden (5), go red (185), colour (149), glow (3), cleanse (12)

Caring for your nephrostomy tubes - patient information

Description: Guide to caring for your nephrostomy tubes
Url: /Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Caring-for-your-nephrostomy-tubes-1042-PIL.pdf

Blinatumomab

Description: Chemotherapy Protocol Acute lymphoblastic leukaemia (ALL) Blinatumomab (3, 4 day) Regimen • ALL – Blinatumomab (
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Blinatumomab.pdf

Ferinject (gynaecology) - patient information

Description: This factsheet explains what Ferinject is, what the treatment involves and what the possible side effects are.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Ferinject-gynaecology-patient-information.pdf

Alternatives to HRT for symptoms of the menopause - patient information

Description: This factsheet contains some non-hormonal alternatives and lifestyle changes you can try to help manage your menopausal symptoms.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Alternatives-to-HRT-for-symptoms-of-the-menopause-3081-PIL.pdf

Ferinject - patient information

Description: Ferinject is special type of iron preparation given through a drip into a vein (also known as an 'infusion'). Ferinject is
Url: /Media/UHS-website-2019/Patientinformation/Pregnancyandbirth/Ferinject.pdf

Percutaneous endoscopic gastrostomy (PEG) tube insertion aftercare advice - patient information

Description: This factsheet explains what to expect after a percutaneous endoscopic gastrostomy (PEG) tube insertion and how to look after your PEG
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Percutaneous-endoscopic-gastrostomy-PEG-tube-insertion-aftercare-advice-3645-PIL.pdf

Follow up after breast cancer - patient information

Description: This booklet explains what self-supported management is after treatment for early breast cancer and how it works.
Url: /Media/UHS-website-2019/Patientinformation/Cancercare/Follow-up-after-breast-cancer-1107-PIL.pdf

AmB-LISOCEL-Cyclophosphamide (300)-Fludarabine (30)

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY AmB – LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) Ambulatory Regimen
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/AmB-LISOCEL-Cyclophosphamide-300-Fludarabine-30.pdf

Lisocel – Cyclophosphamide (300) – Fludarabine (30) Ver1

Description: Chemotherapy Protocol CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T) THERAPY LISOCEL – CYCLOPHOSPHAMIDE (300) – FLUDARABINE (30) This regimen will only be
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lisocel-–-Cyclophosphamide-300-–-Fludarabine-30.pdf

AmsacrineCytarabineEtoposide_MACE

Description: Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA AMSACRINE-CYTARABINE-ETOPOSIDE In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Amsacrine-Cytarabine-Etoposide (MACE) Indication
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AmsacrineCytarabineEtoposide-MACE.pdf

1 to 10 of 183

Previous 1 2 3 4 5 … Next